From the laboratory to the clinic: How translational studies in animals have lead to clinical advances in boron neutron capture therapy

Barth, Rolf F.

doi:10.1016/j.apradiso.2015.06.016

Title: From the laboratory to the clinic: How translational studies in animals have lead to clinical advances in boron neutron capture therapy

Full Record
Other Related Research

Authors:: Barth, Rolf F.

Publication Date:: Tue Dec 01 00:00:00 EST 2015

Sponsoring Org.:: USDOE

OSTI Identifier:: 1250622

Resource Type:: Publisher's Accepted Manuscript

Journal Name:: Applied Radiation and Isotopes

Additional Journal Information:: Journal Name: Applied Radiation and Isotopes Journal Volume: 106 Journal Issue: C; Journal ID: ISSN 0969-8043

Publisher:: Elsevier

Country of Publication:: United Kingdom

Language:: English

Citation Formats


                    Barth, Rolf F. From the laboratory to the clinic: How translational studies in animals have lead to clinical advances in boron neutron capture therapy.  United Kingdom: N. p., 2015. 
Web.  doi:10.1016/j.apradiso.2015.06.016.

Copy to clipboard


                    Barth, Rolf F. From the laboratory to the clinic: How translational studies in animals have lead to clinical advances in boron neutron capture therapy.  United Kingdom.  https://doi.org/10.1016/j.apradiso.2015.06.016

Copy to clipboard


                    Barth, Rolf F. Tue .  
"From the laboratory to the clinic: How translational studies in animals have lead to clinical advances in boron neutron capture therapy".  United Kingdom.  https://doi.org/10.1016/j.apradiso.2015.06.016.

Copy to clipboard


                    
@article{osti_1250622,

  title        = {From the laboratory to the clinic: How translational studies in animals have lead to clinical advances in boron neutron capture therapy},

  author       = {Barth, Rolf F.},

  abstractNote = {},

  doi          = {10.1016/j.apradiso.2015.06.016},

  journal      = {Applied Radiation and Isotopes},

  number       = C,

  volume       = 106,

  place        = {United Kingdom},

  year         = {Tue Dec 01 00:00:00 EST 2015},

  month        = {Tue Dec 01 00:00:00 EST 2015}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (Publisher)

Publisher's Version of Record
https://doi.org/10.1016/j.apradiso.2015.06.016

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 5 works

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

Neutronics design of the INEL (Idaho National Engineering Laboratory) facility for boron neutron capture therapy clinical trials

Conference Parsons, D. K. ; Wheeler, F. J. ; Rushton, B. L. ; ...

The PBF reactor at INEL has been redesigned for BNCT treatment of Gliobiastoma Multiforme. Analysis indicates that the design goals of 1.0E + 10 n/cm{sup 2}{center dot}s epithermal neutron flux at the beam port can be met without exceeding the design goals of 2.6E -11 J cGy/(n/cm{sup 2}) for the fast neutron KERMA and 2.0E-11 cGy/(n/cm{sup 2}) for the gamma KERMA. These design goals result in a 10 minute patient treatment time with low nondesirable doses. 12 refs., 5 figs., 1 tab.
Full Text Available
Clinical trials of boron neutron capture therapy [in humans] [at Beth Israel Deaconess Medical Center][at Brookhaven National Laboratory]

Technical Report Wallace, Christine

Assessment of research records of Boron Neutron Capture Therapy was conducted at Brookhaven National Laboratory and Beth Israel Deaconess Medical Center using the Code of Federal Regulations, FDA Regulations and Good Clinical Practice Guidelines. Clinical data were collected from subjects' research charts, and differences in conduct of studies at both centers were examined. Records maintained at Brookhaven National Laboratory were not in compliance with regulatory standards. Beth Israel's records followed federal regulations. Deficiencies discovered at both sites are discussed in the reports.
https://doi.org/10.2172/811796

Full Text Available
The radiobiology of boron neutron capture therapy: Studies using small animals

Conference Coderre, J A ; Oxford Univ., ; Morris, G M ; ...
Full Text Available
Clinical phase-I study of Na[sub 2]B[sub 12]H[sub 11]SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT)

Journal Article Haritz, D ; Gabel, D ; Huiskamp, R - International Journal of Radiation Oncology, Biology and Physics; (United States)

Within the European collaboration on boron neutron capture therapy (BNCT), a clinical Phase I study is being carried out to establish BNCT as an alternative treatment modality for malignant glioma (WHO III/IV). Data about the pharmacokinetics, biodistribution and toxicity of the boron compound Na[sub 2]B[sub 12]H[sub 11]SH (BSH) are of great importance to avoid radiation damage of healthy tissue and to deliver a sufficient radiation dose. Twenty four patients suffering from a glioblastoma multiforme entered the study to date, infused with a maximum concentration of up to 50 mg BSH/kg. Boron concentration measurements in tissues, urine, and blood were carriedmore »« less
https://doi.org/10.1016/0360-3016(94)90492-8
Correlation of clinical outcome to the estimated radiation dose from Boron Neutron Capture Therapy (BNCT)

Conference Chadha, M ; Coderre, J A ; Chanana, A D

A phase I/II trial delivering a single fraction of BNCT using p-Boronophenylalanine-Fructose and epithermal neutrons at the the Brookhaven Medical Research Reactor was initiated in September 1994. The primary endpiont of the study was to evaluate the feasibility and safety of a given BNCT dose. The clinical outcome of the disease was a secondary endpoint of the study. The objective of this paper is to evaluate the correlation of the clinical outcome of patients to the estimated radiation dose from BNCT.
Full Text Available

Similar Records